by ARSACS | Jun 27, 2022 | Latest News
30 countries are represented in the ARSACS International Patient Registry. Map of registrants. To all of you who are registered, thank you for your participation and for helping the research. The registry is an essential tool for advancing research and for clinical...
by ARSACS | Jun 16, 2022 | Latest News
“Structural Determination and Super Resolution Imaging of Sacsin” research report under the leadership of Dr. Houry from the University of Toronto and funded by the Foundation in 2021-2022.
by ARSACS | Jun 7, 2022 | Latest News
The TREAT-ARCA project, which began in June 2021, is a pre-clinical research project focused on two rare ataxias: ARSACS and COQ8A-ataxia. The objectives are to test promising repurposed and novel drugs for ARSACS, to test gene therapy and identify and validate...
by ARSACS | May 25, 2022 | Latest News
by ARSACS | Apr 19, 2022 | Latest News
Research report from the Krogan Lab at UCSF for the project “Discovery of new targets for therapeutic interventions in ARSACS disease”, project under the leadership of Dr. Nevan Krogan and funded by the Foundation in 2020-2021.
by ARSACS | Mar 28, 2022 | Latest News
“Recessive cerebellar and afferent Ataxias – clinical challenges and future directions”, research article by Dr. Nicolas Dupré and his team published in the Nature Reviews | Neurology journal on March 24, 2022.
by ARSACS | Mar 7, 2022 | Latest News
The Organizzazione di volontariato (ODV) finances 2 ARSACS projects with the support from the Fondazione Telethon. Project details. ODV is a volunteer organisation founded by Susanna Deluca and Dr. Paolo Arrigoni and dedicated to the ARSACS...
by ARSACS | Feb 26, 2022 | Latest News
In light of Rare Disease Day, watch the inspiring story of Ally and her family. We are motivated by her courage, her strength and her determination in finding a treatment for ARSACS.
by ARSACS | Feb 25, 2022 | Latest News
Thank you if you have completed already the PROSPAX survey #2. We still need a greater representation of people with ARSACS for the research. Therefore, the deadline has been extended to Sunday March 6. Please take few minutes to provide your insight so people with...
by ARSACS | Feb 22, 2022 | Latest News
by ARSACS | Feb 16, 2022 | Latest News
Brief summary of the results of Dr. Maltecca’s research project “Targeting deregulated calcium homeostasis as potential therapeutic option for ARSACS”. The results indicate that targeting calcium may represent a therapeutic option for ARSACS.
by ARSACS | Feb 3, 2022 | Latest News
Make your voice heard. Let researchers know what is important to you and how you feel living with the condition.You do not need to have completed the first survey to fill out this survey. A parent of a child can fill out the survey. PROSPAX is a 3 year...
by ARSACS | Feb 1, 2022 | Latest News
If you are interested in joining the team of researchers around the world to advance the understanding of ARSACS and lead to a treatment, please send us your proposal. For details : Financing Offer and ARSACS Appendix. Deadline : May 27, 2022.
by ARSACS | Jan 25, 2022 | Latest News
ARSACS research conducted by Dr. Federico Herrera and his team in Portugal,“Sacsin Deletion Induces Aggregation of Glial Intermediate Filaments” , published in the Cells Journal on January 16, 2022.
by ARSACS | Jan 21, 2022 | Latest News
ARSACS research project, led by Drs. Mckinney ,Watt and Toscano- Marquez, was featured on CBC radio “Let’s Go” on 2022-01-20. As part of the “Understanding the Brain” segment, Rackeb Tesfaye, science columnist at CBC radio and a PHD...
by ARSACS | Jan 2, 2022 | Latest News
” To all of you : Mr. Marc Bédard, Honorary President, sponsors, partners, donors and volunteers, it is thanks to you that the Foundation can pursue it’s mission. Thank you! ” Jean Groleau , president of the Ataxia Charlevoix-Saguenay Foundation. The Diner des...
by ARSACS | Dec 22, 2021 | Latest News
Latest news release from McGill University, Montreal- Researchers at McGill University, lead by Drs. Alanna Watt and Anne Mckinney, have made an important step forward in understanding the cause of ARSACS. “We have shown really clearly that zebrin-negative cells in...
by ARSACS | Dec 21, 2021 | Latest News
The Ataxia Charlevoix-Saguenay Foundation is pleased to announce that Dr. Massimo Pandolfo has joined its board of directors. Dr. Pandolfo is Professor of Neurology at McGill University in Montreal since January 2021. Prior, he was Professor of neurology and Director...
by ARSACS | Dec 18, 2021 | Latest News
Research of Drs. Nethisinghe and Giunti, “Hsp90 Inhibition: A Promising Therapeutic Approach for ARSACS”, was published in the International Journal of Molecular Sciences in October 2021. This research was made possible thanks to the Foundation in...
by ARSACS | Dec 16, 2021 | Latest News
Me Jean Groleau, co-founder and president of the Fondation de l’Ataxie Charlevoix-Saguenay, is proud to join Catalis to represent the needs and challenges of people with rare diseases. Launched in 2017, CATALIS’ mandate is, among other things, to...
